Technical Analysis:
SRF Limited (NSE: SRF) closed at ₹2,885.4 on December 5, 2025, marking a 1.60% gain from the previous close of ₹2,840.1, with intraday movement from a low of ₹2,828.3 to a high of ₹2,891.6 on volume of 376,427 shares (below average 423,487). Key indicators show RSI(14) at 33.48 in oversold territory, MACD at -32.79 (bearish), Stochastic %K at 13.5 (strong oversold), and Williams %R at -99, signaling potential short-term bounce but overall “Strong Sell” on daily timeframe with all moving averages (5-day: ~₹3,060, 20-day: ~₹3,130, 50-day: ₹2,943, 200-day: ₹2,975) acting as resistance. Critical support lies at ₹2,796-₹2,828 (recent lows and pivot S1), with resistance at ₹3,050 (20-day MA) and ₹3,192 (gap fill); today’s bottom-to-high move of ~2.25% indicates initial recovery but lacks conviction without volume surge—buying at current levels carries risk of further 5-7% downside to ₹2,650 if support breaks, so wait for confirmation above ₹2,900 with SL below ₹2,796.
Fundamental Analysis:
SRF boasts a market cap of ₹85,530 Cr, TTM EPS of ₹54.62 (up 43% YoY), trailing PE of 52.83 (below sector average 73.30), P/B of 6.78, ROE of 9.90%, and low debt-to-equity of 0.37 reflecting a robust balance sheet in specialty chemicals and fluorochemicals. Q2FY26 results (ended Sep 2025) delivered revenue of ₹3,640 Cr (+6% YoY), EBIT ₹650 Cr (+56%), and PAT ₹388 Cr (+93%), driven by volume growth in packaging films and operational efficiencies despite pricing pressures; 5-year revenue CAGR stands at 15%, with ROCE at 12%. Long-term strengths include import substitution, export surge (68% YoY in CO exports Oct 2025), and diversified segments (chemicals 45%, packaging 30%, technical textiles 15%), though high valuation and cyclical raw material costs warrant caution—intrinsic value estimates suggest 10-15% upside to ₹3,200-₹3,500 over 12 months.
Key Events and Impacts:
Q2FY26 Earnings (Oct 27, 2025): Strong PAT growth of 93% beat estimates, boosting margins via cost controls, but stock fell 5% post-results on muted revenue guidance; positive long-term catalyst for chemical segment recovery.
Chemours Strategic Partnership (Aug 2025): Agreements for fluoropolymers supply in India enhance export capabilities and market share, aligning with 68% YoY CO export surge in Oct 2025—expected to add ₹500-700 Cr annual revenue by FY27.
Elevated Put Option Activity (Nov 2025): Heavy OI buildup at ₹2,900 strike ahead of Dec expiry signals bearish bets amid volatility, contributing to recent 15% correction from YTD high of ₹3,325—heightens short-term downside risk.
Micro and Macro Views:
Micro View (Short-Term: 1-3 Months)
Oversold oscillators (RSI 33, Stoch 13.5) from today’s ₹2,828 bottom suggest bounce potential to ₹3,050, but bearish MA alignment and sub-average volume indicate fragility—avoid fresh buys below ₹2,900; further dip to ₹2,650 possible if Nifty weakness persists, target 8-10% upside on breakout with tight SL.
Macro View (Long-Term: 6-24 Months)
Bullish on fluorochemicals leadership, capex expansion (₹4,000 Cr planned), and global EV/refrigerant demand driving 12-15% CAGR; headwinds from China dumping offset by partnerships—base case target ₹3,650 (25% upside), bull ₹4,000 if exports double.
Disclaimer and Disclosure:
This report is for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results; markets involve risks, and investors should consult independent advisors. Investogainer Research or the author holds no position in SRF. Prepared by SEBI-registered Research Analyst; no guarantees provided.